Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children (Q67927081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

F. Bessho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861208

12 December 2022

K. Hashizume

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861208

12 December 2022

T. Nakajo

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861208

12 December 2022

S. Kamoshita

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861208

12 December 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:S0022347605807334?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0022-3476(05)80733-4

https://api.elsevier.com/content/article/PII:S0022347605807334?httpAccept=text/plain

12 December 2022

1 reference

DOI

https://api.crossref.org/works/10.1016/S0022-3476(05)80733-4

The Journal of Pediatrics

12 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

237-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

Neuroblastoma, its natural history and prognosis: a study of 487 cases.

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Neuroblastoma. Mass screening for early detection and its prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Screening for neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Screening for neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Neuroblastoma IV-S: chromosome analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Do infants with stage IV-S neuroblastoma need treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Chromosomes and screening for neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Cases of neuroblastoma missed by the mass screening programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Stage IV-S neuroblastoma. Results with definitive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

IV-S neuroblastoma: a cooperative study of 30 children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Problems of mass screening for neuroblastoma: analysis of false-negative cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980733-4

Mass screening of neuroblastoma in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)80733-4

Different karyotypic patterns in early and advanced stage neuroblastomas

12 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)80733-4

Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients

12 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(05)80733-4

12 December 2022

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861208%20AND%20SRC:MED&resulttype=core&format=json